HomeCompareESGRO vs MRK

ESGRO vs MRK: Dividend Comparison 2026

ESGRO yields 9.11% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESGRO wins by $3.13M in total portfolio value
10 years
ESGRO
ESGRO
● Live price
9.11%
Share price
$19.21
Annual div
$1.75
5Y div CAGR
46.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.18M
Annual income
$2,177,239.39
Full ESGRO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ESGRO vs MRK

📍 ESGRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESGROMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESGRO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESGRO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESGRO
Annual income on $10K today (after 15% tax)
$774.34/yr
After 10yr DRIP, annual income (after tax)
$1,850,653.48/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ESGRO beats the other by $1,842,325.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESGRO + MRK for your $10,000?

ESGRO: 50%MRK: 50%
100% MRK50/50100% ESGRO
Portfolio after 10yr
$1.62M
Annual income
$1,093,518.76/yr
Blended yield
67.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ESGRO
No analyst data
Altman Z
0.9
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESGRO buys
0
MRK buys
0
No recent congressional trades found for ESGRO or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESGROMRK
Forward yield9.11%2.76%
Annual dividend / share$1.75$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.9%32.7%
Portfolio after 10y$3.18M$56.8K
Annual income after 10y$2,177,239.39$9,798.13
Total dividends collected$3.06M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESGRO vs MRK ($10,000, DRIP)

YearESGRO PortfolioESGRO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,038$1,338.24$11,206$366.19+$832.00ESGRO
2$15,093$2,211.74$12,650$502.35+$2.4KESGRO
3$19,956$3,806.92$14,407$694.19+$5.5KESGRO
4$28,264$6,910.69$16,585$967.82+$11.7KESGRO
5$43,679$13,437.33$19,342$1,363.89+$24.3KESGRO
6$75,247$28,510.17$22,913$1,947.19+$52.3KESGRO
7$147,944$67,429.64$27,662$2,823.89+$120.3KESGRO
8$340,311$182,010.46$34,159$4,173.35+$306.2KESGRO
9$938,926$574,793.96$43,337$6,308.80+$895.6KESGRO
10$3,181,891$2,177,239.39$56,776$9,798.13+$3.13MESGRO

ESGRO vs MRK: Complete Analysis 2026

ESGROStock

Enstar Group Limited acquires and manages insurance and reinsurance companies, and portfolios of insurance and reinsurance business in run-off. It engages in the run-off property and casualty, and other non-life lines insurance businesses. The company also provides consulting services, including claims inspection, claims validation, reinsurance asset collection, syndicate management, and IT consulting services to the insurance and reinsurance industry. It operates in Bermuda, the United States, the United Kingdom, Australia, and other Continental European countries. The company was formerly known as Castlewood Holdings Limited and changed its name to Enstar Group Limited in January 2007. The company was founded in 1993 and is headquartered in Hamilton, Bermuda.

Full ESGRO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ESGRO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESGRO vs SCHDESGRO vs JEPIESGRO vs OESGRO vs KOESGRO vs MAINESGRO vs JNJESGRO vs ABBVESGRO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.